Empagliflozin Targets NF-κB Signaling Through PTGS2 and TLR4 in Polycystic Ovary Syndrome: A Drug Repurposing Study and Molecular Simulation

Ikhwandi Chandra Nugraha, Ami Febriza, Asdar Tajuddin, Suryani As’ad

Open source

DOI
10.3390/jox16050169
Published
2026-09-07
Container
Journal of Xenobiotics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jox16050169,
  title = {Empagliflozin Targets NF-κB Signaling Through PTGS2 and TLR4 in Polycystic Ovary Syndrome: A Drug Repurposing Study and Molecular Simulation},
  author = {Ikhwandi Chandra Nugraha and Ami Febriza and Asdar Tajuddin and Suryani As’ad},
  year = {2026},
  journal = {Journal of Xenobiotics},
  doi = {10.3390/jox16050169},
  url = {https://doi.org/10.3390/jox16050169}
}

RIS

TY  - JOUR
TI  - Empagliflozin Targets NF-κB Signaling Through PTGS2 and TLR4 in Polycystic Ovary Syndrome: A Drug Repurposing Study and Molecular Simulation
AU  - Ikhwandi Chandra Nugraha
AU  - Ami Febriza
AU  - Asdar Tajuddin
AU  - Suryani As’ad
PY  - 2026
JO  - Journal of Xenobiotics
DO  - 10.3390/jox16050169
UR  - https://doi.org/10.3390/jox16050169
ER  - 

APA

Nugraha, I. C., Febriza, A., Tajuddin, A., & As’ad, S. (2026). Empagliflozin Targets NF-κB Signaling Through PTGS2 and TLR4 in Polycystic Ovary Syndrome: A Drug Repurposing Study and Molecular Simulation. Journal of Xenobiotics. https://doi.org/10.3390/jox16050169

Source records